ID: ALA2381370

Max Phase: Preclinical

Molecular Formula: C18H17N3O2

Molecular Weight: 307.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)c1ccc(-n2cc(C(=O)c3ccccc3O)nn2)cc1

Standard InChI:  InChI=1S/C18H17N3O2/c1-12(2)13-7-9-14(10-8-13)21-11-16(19-20-21)18(23)15-5-3-4-6-17(15)22/h3-12,22H,1-2H3

Standard InChI Key:  LECSTSNQQMMMFP-UHFFFAOYSA-N

Associated Targets(Human)

Estrogen-related receptor alpha 573 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1321AlogP: 3.33#Rotatable Bonds: 4
Polar Surface Area: 68.01Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.97CX Basic pKa: CX LogP: 5.11CX LogD: 4.56
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -1.30

References

1. Xu S, Zhuang X, Pan X, Zhang Z, Duan L, Liu Y, Zhang L, Ren X, Ding K, Ding K..  (2013)  1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α.,  56  (11): [PMID:23656512] [10.1021/jm4003928]

Source